421 results on '"Mahoney, Kathleen"'
Search Results
2. A Strategy for Achieving Indigenous Justice
3. Regulation of HHLA2 expression in kidney cancer and myeloid cells
4. Gender bias in family law
5. Indigenous Legal Principles: A Reparation Path for Canada's Cultural Genocide
6. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
7. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy
8. The importance of exosomal PDL1 in tumour immune evasion
9. Acidity changes immunology: a new VISTA pathway
10. The Rise of the University and the Secularization of the Academy: The Role of Liberal Protestantism
11. A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
12. Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
13. Abstract A005: Regulation of HHLA2 expression in renal cell carcinoma and myeloid cells
14. Response to the Reviewers ofThe Resilience of Religion in American Higher Education
15. RevisitingThe Resilience of Religion in American Higher Education: The Argument and an Update
16. The Problem of the past in the Modern University: Catholics and Classicists, 1860-1900
17. Musicality in nineteenth-century French poetry prior to the emergence of free verse : Baudelaire, MallarmeÌ
18. THE UNTOLD STORY: HOW INDIGENOUS LEGAL PRINCIPLES INFORMED THE LARGEST SETTLEMENT IN CANADIAN LEGAL HISTORY.
19. Immune Checkpoint Inhibition in Renal Cell Carcinoma
20. The Past, Present and Future of Asbestos-Related Diseases in Australia: What Are the Data Telling Us?
21. Data from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1
22. Supplementary Figures and Tables from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1
23. Data from PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
24. Data from Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
25. Supplemental Figures 1-4 from PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
26. Supplemental Figure and Table Legends from Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
27. Supplemental Table I from PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
28. Supplemental Figure and Table Legends from PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
29. Supplemental Figures and Tables from Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
30. Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
31. Learning from PD-1 Resistance: New Combination Strategies
32. Substance Use Disorder: Prenatal, Intrapartum and Postpartum Care
33. Reforming reparations for mass human rights abuses
34. Supplementary Figures 1-8 from Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
35. Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors
36. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
37. Resilience and Coping After Hospital Mergers
38. Blood Management Strategies to Reduce Transfusions After Elective Lower-Extremity Joint Arthroplasty Surgeries: One Tertiary Care Hospital’s Early Experience With an Alternative Payment Model—a Total Joint “Bundle”
39. Revisiting The Resilience of Religion in American Higher Education: The Argument and an Update.
40. Response to the Reviewers of The Resilience of Religion in American Higher Education.
41. american scholars return to studying religion
42. One Hundred Years: The Association of Catholic Colleges and Universities.
43. Soluble PD-L1 as an early marker of progressive disease on nivolumab
44. Reconciliation and the Indian Residential Schools Settlement
45. 377 Characterization of peripheral biomarkers of GS-1423, a first in class bifunctional anti-CD73-TGFβ receptor II- trap molecule, in a phase 1 dose escalation study in patients with advanced solid tumors
46. Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
47. Objective Structured Clinical Examination and Advanced Practice Nursing Students
48. The Canadian Constitutional Approach to Freedom of Expression in Hate Propaganda and Pornography
49. Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study
50. Rare case: Ureteropelvic junction complication presenting with bilateral labial abscesses and urosepsis requiring nephrectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.